Aldurazyme® is approved in the 15 European Union countries, Iceland and Norway. This site will contain information for healthcare professionals and will be for use by physicians practicing in countries where Aldurazyme is approved.
DocCheck AG er et selskab, der er noteret på den tyske aktiebørs, som specialiserer sig i det voksende sundhedsmarked.
Aldurazyme® is approved in the 15 European Union countries, Iceland and Norway. This site will contain information for healthcare professionals and will be for use by physicians practicing in countries where Aldurazyme is approved.